4//SEC Filing
Weiss Amir 4
Accession 0000950170-24-025863
CIK 0000818686other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:03 PM ET
Size
13.2 KB
Accession
0000950170-24-025863
Insider Transaction Report
Form 4
Weiss Amir
Chief Accounting Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2024-03-03+5,179→ 19,074 total - Exercise/Conversion
Ordinary Shares
2024-03-04+10,676→ 29,750 total - Exercise/Conversion
Restricted Share Units
2024-03-03−5,179→ 15,538 total→ Ordinary Shares (5,179 underlying) - Exercise/Conversion
Restricted Share Units
2024-03-04−10,676→ 21,355 total→ Ordinary Shares (10,676 underlying) - Award
Restricted Share Units
2024-03-04+22,600→ 22,600 total→ Ordinary Shares (22,600 underlying)
Footnotes (5)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on March 3, 2023, with 5,179 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 5,180 vesting on March 3, 2027.
- [F4]Restricted share units were granted on March 4, 2022, with 10,676 vested on March 4, 2023 and March 4, 2024, 10, 676 vesting on March 4, 2025 and 10,679 vesting on March 4, 2026.
- [F5]Restricted share units were granted on March 4, 2024, with 5,650 vesting on each of March 4, 2025, March 4, 2026, March 4, 2027, and March 4, 2028.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001897057
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:03 PM ET
- Size
- 13.2 KB